• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小细胞肺癌(SCLC)患者骨髓和外周血细胞的G显带染色体分析]

[G-banded chromosome analysis of bone marrow and peripheral blood cells from small cell lung cancer (SCLC) patients].

作者信息

Su Y, Wang X Q, Wu M, Tang Z Z, Kong L H, Wang Y L, Chen L M

机构信息

Cancer Institute, Chinese Academy of Medical Sciences, Beijing.

出版信息

Zhonghua Zhong Liu Za Zhi. 1987 Jul;9(4):251-4.

PMID:2824149
Abstract

Detailed G-banded chromosome analysis was carried out on the bone marrow and/or PHA-stimulated peripheral blood cells from 17 SCLC patients (14 males and 3 females), who were diagnosed cytologically or pathologically or both. Twelve of them had no prior treatment and 16 had a heavy smoking history. High chromosome aberration rates were found in the bone marrow (31% for average structural aberration rate and 63% for numerical aberration rate) and peripheral blood cells (37% for average structural aberration rate and 49% for numerical aberration rate). The smoking index, as a whole, was positively correlated to the structural chromosome aberration rate, indicating that smoking is one of the most important environmental factors in causing chromosome aberrations. But some patients gave a high aberration rate dis-proportional to their smoking index, suggesting that genetically determined susceptibility to smoking or even other factors also play an important role. The structural chromosome aberrations in the bone marrow and peripheral blood cells were mainly clustered on chromosome 3 and chromosomes 1, 9 and 11, respectively. The aberration types were manifold and complicated. No consistent or specific aberration as del 3p14-23 for SCLC was found in this study.

摘要

对17例经细胞学或病理或两者确诊的小细胞肺癌患者(14例男性,3例女性)的骨髓和/或PHA刺激的外周血细胞进行了详细的G显带染色体分析。其中12例未曾接受过治疗,16例有重度吸烟史。在骨髓中发现高染色体畸变率(平均结构畸变率为31%,数目畸变率为63%),在外周血细胞中也发现高染色体畸变率(平均结构畸变率为37%,数目畸变率为49%)。总体而言,吸烟指数与染色体结构畸变率呈正相关,表明吸烟是导致染色体畸变的最重要环境因素之一。但有些患者的畸变率与其吸烟指数不成比例,提示遗传决定的对吸烟的易感性甚至其他因素也起重要作用。骨髓和外周血细胞中的染色体结构畸变主要分别聚集在3号染色体以及1、9和11号染色体上。畸变类型多样且复杂。本研究未发现小细胞肺癌中一致或特异的畸变,如3p14 - 23缺失。

相似文献

1
[G-banded chromosome analysis of bone marrow and peripheral blood cells from small cell lung cancer (SCLC) patients].[小细胞肺癌(SCLC)患者骨髓和外周血细胞的G显带染色体分析]
Zhonghua Zhong Liu Za Zhi. 1987 Jul;9(4):251-4.
2
Chromosome alterations in human small cell lung cancer: frequent involvement of 5q.人类小细胞肺癌中的染色体改变:5号染色体长臂频繁受累。
Cancer Res. 1992 Mar 1;52(5):1322-8.
3
Cytogenetic diagnosis of cancer: abnormalities of chromosomes and polyploid levels in the bone marrow of patients with small cell anaplastic carcinoma of the lung.
J Natl Cancer Inst. 1978 Oct;61(4):1065-75.
4
Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinoma.检测小细胞肺癌患者骨髓和外周血中的肿瘤特异性基因表达。
Cancer. 2003 Feb 15;97(4):1057-62. doi: 10.1002/cncr.11108.
5
[Cytogenetic studies on one human small cell lung cancer (SCLC) cell line, LTEP-sm].[对一株人小细胞肺癌(SCLC)细胞系LTEP-sm的细胞遗传学研究]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1990 Oct;12(5):348-52.
6
[The types and breakpoints of somatic chromosome aberrations in small cell lung cancer (SCLC) patients and heavy smokers].[小细胞肺癌(SCLC)患者及重度吸烟者体细胞染色体畸变的类型和断点]
Yi Chuan Xue Bao. 1988;15(2):150-60.
7
Heterogeneous cytogenetic abnormalities in small cell lung cancer cell lines.小细胞肺癌细胞系中的异质性细胞遗传学异常。
Cancer Res. 1987 Jun 15;47(12):3322-7.
8
Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers.
Cancer Res. 1987 Dec 1;47(23):6278-82.
9
Molecular genetics of small cell lung carcinoma.小细胞肺癌的分子遗传学
Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13.
10
Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients.
Anticancer Res. 1996 May-Jun;16(3A):1187-92.